Analysis of the COMPARE-AMI trial: First report of long-term safety of CD133+ cells.
Haddad K, Potter BJ, Matteau A, Reeves F, Leclerc G, Rivard A, Gobeil F, Roy DC, Noiseux N, Mansour S.
Haddad K, et al. Among authors: leclerc g.
Int J Cardiol. 2020 Nov 15;319:32-35. doi: 10.1016/j.ijcard.2020.06.004. Epub 2020 Jun 15.
Int J Cardiol. 2020.
PMID: 32553596
Clinical Trial.